首页|Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia

Identification of TMEM217 as a novel prognostic biomarker and potential therapeutic target in acute myeloid leukemia

扫码查看

Yunying Yao、Zhizhou Xia、Min Wu、Bo Jiao、Jiaming Gao、Donghe Li、Xi Xie、Pengfei Xu、Jiaoyang Li、Lei Yan、Ruibao Ren、Ping Liu

展开 >

Shanghai Institute of Hematology,State Key Laboratory for Medical Genomics,National Research Center for Translational Medicine,Collaborative Innovation Center of Hematology,Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China

International Center for Aging and Cancer,Hainan Medical University,Haikou,Hainan 570102,China

国家自然科学基金重点项目国家自然科学基金国家自然科学基金国家自然科学基金国家自然科学基金国家自然科学基金Shanghai Science and Technology Development Funds(China)Shanghai Science and Technology Development Funds(China)Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research(China)Samuel Waxman Cancer Research FoundationInnovative Research Team of High-Level Local Universities in Shanghai,China国家重点研发计划

82230088818701128217014781970134821701118220020020Z1190020018ZR14236002019CXJQ012022YFC2705004

2024

基因与疾病(英文)

基因与疾病(英文)

ISSN:
年,卷(期):2024.11(4)